Background: Preeclampsia is associated with impaired antioxidant defense that results in maternofetal complications. In addition to antioxidant defi ciency, hemolytic disorder has also been observed in preeclamptic mother.
Abbreviations: RBC -Red blood cell, HBSS -Hank's Balanced Salt Solution, HELLP -Hemolytic anemia Elevated Liver enzymes and Low Platelet count, DPPH -2,2-diphenyl-1-picrylhydrazyl, MDA -Malondialdehyde, G6PDH -Glucose 6-phosphate dehydrogenase, H 2 O 2 -Hydrogen peroxide, TAC -Toatal antioxidant capacity, ABTS 2, -2'-azinobis-3-ethyl-benzothiozoline-6-sulphonic acid, ROS -Reactive oxygen species, RNS -Reactive nitrogen species, NO 2 --Nitrite, NO 3 --Nitrate, IC 50 -half maximal inhibitory concentration, LPO -Lipid peroxide.
Preeclampsia is a pregnancy-specifi c condition characterized by hypertension and proteinuria that remits after delivery (1) . It is a hypoxic condition (2) , which can increase the number of RBC in cord blood (3) . Umbilical cord blood RBCs (red blood cells) play a vital role in nourishing the fetus (3) . The course of preeclamptic/eclamptic patients may be complicated by HELLP syndrome, syndrome of intravascular hemolysis (H), elevated liver enzymes (EL) and low platelet count (LP) (4) . A case of severe preeclampsia in which hemolysis and rapid platelet consumption persisted after delivery was noted in early 1985 (5) . Hemolytic disorder like the HELLP syndrome has also been observed in preeclamptic mother in addition to antioxidant defi ciency (6) , but similar complication in fetus has not been observed.
Preeclamptic stress in the fetus and the corresponding fetal response are refl ected in the cord blood. Oxidative stress increases during preeclampsia and results in increased production of lipid peroxides (LPO), reactive oxygen species (ROS) and superoxide anion radicals (7, 8) . Antioxidants such as carotenoids, tocopherols, and ascorbic acid are lower in women with preeclampsia (9) . In this context, this study was undertaken to determine the changes in cord blood levels of hemolysis, oxidative stress, nitrative stress and antioxidant levels of RBC in preeclamptic subjects compared to normotensive subjects; for analyzing the fetal complication along with its response to preeclampsia. Various natural alternative medicines have been suggested and utilized for controlling preeclampsia.
Yeast contains a system of antioxidant enzymes that protects them from oxidative injury. Monascus purpureus and Saccharomyces cerevisiae are two most common yeasts having nutritional and medicinal properties more often consumed on the Asian continent. M. purpureus is used as medicinal food to improve blood circulation. It is used to prepare fermented red yeast rice which is commonly consumed in many Asian countries (10, 11) . Other applications for M. purpureus are that lovastatin and other statin drugs produced from this yeast may be useful for treating or pre-venting osteoporosis (12, 13) . It contains Monacolin K, known as lovastatin, which is a commonly prescribed lipid-lowering drug that signifi cantly reduces high cholesterol. M. purpureus contains a large amount of GABA and possesses antihypertensive effects for humans (14) . S. cerevisiae is alternatively regarded as nutritional yeast. S cerevisiae is also found in many commonly consumed Asian food like Dosa, butter, curd, fruit juice and rice cakes (15) . S. cerevisiae has been studied extensively as a dietary supplement due to the rich source of vitamins and minerals present in it (16) . The antioxidant and anti-hemolytic potential of yeast extract was determined through scavenging assays and its ability to inhibit free radical formation through incubation studies with cord blood RBC.
Materials and methods

Selection of sample
About 20 patients with preeclampsia in the age group of 20-40 years were included in the study as test subjects, and 20 normotensive pregnant women of similar age and race were included as control subjects. Patients with preeclampsia were defi ned on the basis of the following clinical and laboratory criteria (Tab. 1); systolic pressure ≥140 mmHg and diastolic pressure ≥90 mmHg noted at least on two occasions, proteinuria levels ≥300 mg/dl found at least in two random specimens. The control group women were without any maternal and fetal complication during their pregnancy period. There were 5 vaginal deliveries and 15 Caesarean sections in the test group, and 16 vaginal deliveries and 4 Caesarean sections in the control group.
Collection of sample
Immediately after the birth of the baby, the umbilical cord was clamped 8-10 inches away from the fi rst clamp and the cord was cut to collect the cord blood. The blood was collected in a sterile heparin-coated vacutainer.
Isolation of RBC
An open syringe, fi lled with cord blood was closed at the tip, kept upright, and then centrifuged at 800g for 20 min at 4 C without the piston. The resulting plasma was discarded. After opening the syringe at the tip, about 2/3 of RBC sediment was carefully allowed to drop out of the syringe and was used for further analysis. The isolated RBCs were confi rmed by performing Glucose 6-phosphate dehydrogenase enzyme assay by the method of Noltmann et al. (17) .
Yeast preparation
The white yeast culture was purchased from a private research laboratory, Chennai, India. The microorganism was maintained by sub-culturing in Potato Dextrose agar slants. The Microbial type culture collection strain (MTCC) of red yeast (MTCC No. 369), was purchased from Indian Institute of Microbial Technology, Chandigarh, India. The fungus was maintained by sub-culturing in potato dextrose agar plates.
Incubation studies of RBC with yeast
100 l of RBCs collected from normotensive and preeclamptic women were incubated with 1 mL of Hanks Balanced Salt Medium containing 5.5 mM glucose (pH 7.4) for 24 h at 37 C in a shaking water bath. The RBCs were then incubated with M. purpureus and S. cerevisiae at appropriate concentration for 2 h at 37 C. Control RBCs were maintained with an equal volume of HBSS (Hank's Balanced Salt Solution) for the same duration at 37 C.
RBC hemolysis in vitro
This was measured after addition of hydrogen peroxide (H 2 O 2 ) with a technique modifi ed from that described by Horwitt et al (18) . A volume of 0.1 mL of RBC was taken in four test tubes. The fi rst tube treated with HBSS serves as a negative control. The second tube treated with 2 % H 2 O 2 serves as the positive control. Tubes 3-4 were treated with 0.1 mL of H 2 O 2 and 0.1 mL of test samples (RBC incubated with M. purpureus and S. cerevisiae). All the tubes were incubated at 37 C for 3 h. All samples were centrifuged, and the absorbance of the supernatant was measured at 575 nm as an indication of the degree of hemolysis.
Determination of antioxidant status of yeast
The activity of catalase was estimated by the method of Beer et al (19) . The enzyme activity was expressed as Units/mg protein. DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging ability was determined by the method of Viturro et al (20) . Vitamin-C was used as a standard. Nitric oxide radical inhibition activity was determined by the method of Garrat (21) . Rutin was used as a standard. Superoxide anion scavenging ability was measured by the method of Nagai et al (22) . Curcumin was used as a positive control. Hydroxyl radical scavenging activity was determined by method of Halliwell et al (23) . Vitamin E was used as a standard. The reducing power was determined according to the method de- veloped by method of Oyaizu (24) . Butylated hydroxy toluene was used as a standard. Total antioxidant capacity of yeast extracts was evaluated by the method of Erel (25) . Gallic acid was used as a standard. Total phenolic content of yeast extract was determined by method of Chandler and Dodds (26) . Gallic acid was used as a standard. The phyto-components present in the aqueous extract of M. purpureus and S. cerevisiae were identifi ed by means of qualitative analysis.
Determination of oxidative and nitrative stress
The levels of LPO were determined by the method of Ohkawa et al (27) . The LPO content was expressed as nanomoles of MDA (Malondialdehyde)/mg protein. Nitrite and nitrate were estimated by the method of Yokoi et al (28) . The results were expressed as μmol/mg protein.
Determination of antioxidant status in RBC after incubation
The activity of catalase was estimated by the method of Beer et al (19) . The enzyme activity was expressed as Units/mg protein.
Total antioxidant capacity of the yeast extracts was evaluated by the method of Erel (25) .
Statistical analysis
Data were analyzed using statistical software package. Student's t-test, Two-way ANOVA was used to ascertain the signifi cance of variations between normotensive and preeclamptic pregnant women. All data were presented as mean ± SD of 20 subject samples. Differences were considered signifi cant at p<0.05, p<0.001. The hemolytic activity was expressed as medians for better comparative analysis. Further a Spearman rank correlation was performed to the results obtained for the anti-hemolytic activity study.
Results
Clinical Characteristics of the normotensive and preeclampsia samples analyzed are tabulated in Table 1 . The normotensive and preeclamptic subjects selected for analysis had a signifi cant alteration in the values of systolic and diastolic pressure during pregnancy while an insignifi cant change in those of systolic and diastolic pressure prior to pregnancy. There was also a signifi cant decrease in the birth weight of fetus born to preeclamptic mother. Figure 1 M. purpureus demonstrated a highly signifi cant DPPH, superoxide anion, hydroxyl radical scavenging activities (p<0.001) compared to S. cerevisiae. However, S. cerevisiae exhibited a highly signifi cant nitric oxide radical scavenging activity (p<0.001), compared to M. purpureus. The IC 50 values of the two yeast species are demonstrated in Table 2 . The study results confi rmed a signifi cant reducing power (p<0.05) and a highly signifi cant TAC (Total antioxidant capacity) activity (p<0.001) in extracts of M. purpureus when compared with those of S. cerevisiae. The aqueous extract of M. purpureus possessed higher catalase (36.67 Units / mg protein) activity compared to aqueous extract of S. cerevisiae (21.47 Units / mg protein). The levels of antioxidant in the aqueous extracts of M. purpureus and S. cerevisiae are shown in Table 2 . The qualitative analysis demonstrated the presence of phytocomponents like fl avonoids, triterpenoids, alkaloids, saponins, tannins, quinines and coumarins in the aqueous extracts of M. purpureus and S. cerevisiae.
RBCs isolated from normotensive and preeclamptic women were confi rmed by analysis of RBC marker enzyme G6PDH (Glucose 6-phosphate dehydrogenase) and by microscopic analysis using Giemsa staining. There was a signifi cant decrease in the G6PDH level in preeclamptic cord blood RBC when compared to the normotensive cord blood RBC as demonstrated in Table 3 . Levels of LPO and nitrite/nitrate elevated signifi cantly (p<0.05) in preeclamptic subjects when compared with normotensive subjects. Similarly the TAC and catalase values showed a signifi cant (p<0.05) decrease in cord blood RBCs of preeclamptic subjects comparatively (Tab. 3). The incubation study results revealed that the activity of M. purpureus and S. cerevisiae were similar in the normotensive and preeclamptic subjects. The LPO inhibiting effect of the aqueous extract of M. purpureus was signifi cantly higher than (p<0.05) that of aqueous extract of S. cerevisiae in both the samples. The nitrite/nitrate formation inhibiting effect of the aqueous extract of S. cerevisiae was signifi cantly (p<0.05) higher than that of aqueous extract of M. purpureus in both the samples.
The correlation analysis of the anti-hemolytic activity in both the preeclamptic and normotensive samples treated with M. purpureus and S. cerevisiae is tabulated in Table 4 . There was a signifi cant positive correlation between the preeclamptic and normotensive samples treated with M. purpureus, while there was an insignifi cant positive correlation between the normotensive and preeclamptic sample treated with S. cerevisiae, suggesting that the latter yeast species functions effi ciently with increasing stress.
Discussion
Pregnancies complicated by HELLP syndrome are associated with increased materno-fetal mortality and morbidity (29) . A signifi cant increase in H 2 O 2 -induced hemolysis noted in preeclampsia indicates a defi cient antioxidant status in preeclamptic cord blood RBC compared with normotensive cord blood RBC. Surface antioxidants in RBC like vitamin C can lower the H 2 O 2 -induced hemolysis (30) . The signifi cant positive correlation noted in normotensive and preeclamptic cord blood RBC treated with M. purpureus and S. cerevisiae suggest that both yeast species function in a similar manner to reduce the H 2 O 2 -induced hemolysis. The insignifi cant positive correlation in the normotensive and preeclamptic cord blood RBC treated with S. cerevisiae suggests minimal difference in the hemolytic function compared with M. purpureus. The percentage of hemolysis in preeclamptic sample treated with M. purpureus (23 %) and S. cerevisiae (24 %) is near to H 2 O 2 -induced hemolysis in normotensive sample (25 % hemolysis of RBC in preeclampsia after treatment with M. purpureus and S. cerevisiae are similar to that of normotensive sample ( Fig. 1) , indicating that both yeast species are effective in reducing the ROS-mediated hemolysis in the preeclamptic sample. Studies have demonstrated that oxidative stress is one of the key factors in complicating preeclampsia which results in preterm birth (31) . Oxidative stress is the presence of ROS in excess of the buffering capacity of available antioxidants (32) . Free radicals and other damaging ROS such as superoxide anions are involved in oxidative metabolic processes; their activation is thought to increase during preeclampsia (33) . Insuffi cient antioxidant capacity leads to oxidative stress and subsequently the oxidative injury may occur in both the maternal and placental compartments (33) . The increase in oxidative stress and nitrative stress observed in cord blood RBC in this study is in coherence with the evidence observed till date, thus suggesting their signifi cant role in the pathophysiology of preeclampsia (34) . Many studies confi rm that levels of antioxidants are reduced in the sera, placentas and placental mitochondria of preeclamptic women (31, 32, 35, 36) . Similarly in the present study, it was noted that the antioxidant status in preeclamptic cord blood RBC was signifi cantly decreased compared with the normotensive sample. Administration of natural antioxidants in early pregnancy may help in preventing the complication to both mother and fetus during preeclampsia (37) .
Nitric oxide-mediated nitrative stress plays an important role in the pathogenesis of preeclampsia. The increase in nitrite and nitrate levels noted in cord blood RBC in this study indirectly refl ects the increase in nitrative stress during preeclampsia. NO is involved in a wide range of both physiologic and pathologic events. NO can enhance ROS toxicity due to its rapid reaction to form peroxynitrite (ONOO − ). Peroxynitrite is a potentially harmful ROS as it causes nitrosylation of tyrosine residues, leading to changes in protein conformation and its inactivation. The effect of elevation in peroxynitrite, and that of reduced bioavailability of NO result from enhanced production of free radicals.
The resultant placental oxidative state may contribute to the elevation of maternal blood pressure, proteinuria, platelet dysfunction as well as levels of thromboxane and prostacyclin in preeclampsia (38) . In vitro NO inhibition study results showed that S. cerevisiae signifi cantly reduced the levels of nitrite and nitrate in both samples.
Our experimental results suggest that M. purpureus and S. cerevisiae possess a wide range of antioxidant activities. The evaluation of antioxidant activity of aqueous extracts of M. purpureus and S. cerevisiae revealed a highly signifi cant DPPH radical, superoxide anion radical, hydroxyl radical and ABTS .+ (2, 2'-azinobis-3-ethylbenzothiozoline-6-sulphonic acid) radical cation scavenging potentials. However, M. purpureus possessed a signifi cant reducing power whereas S. cerevisiae demonstrated a signifi cant nitric oxide radical scavenging activity. Both yeast species had a signifi cant catalase activity in normotensive and preeclamptic conditions. The aqueous extract of M. purpureus and S. cerevisiae attained the IC 50 values for different scavenging assays at varying concentration compared with standard. M. purpureus reached IC 50 at a lower concentration compared to S. cerevisiae in scavenging free radical whereas the IC 50 value of S. cerevisiae in scavenging RNS was much lower than that of M. purpureus. Preliminary phytochemical analysis demonstrated the presence of various biologically active constituents like fl avonoids, triterpenoids, alkaloids, saponins, tannins, quinines and coumarins in the aqueous extracts of both M. purpureus and S. cerevisiae.
The effi cacy of M. purpureus and S. cerevisiae extracts in quenching ROS and RNS (Reactive nitrogen species) was confi rmed by the inhibition of formation of LPO and nitrite/nitrate in cord blood RBC of preeclamptic and normotensive subjects. Both extracts decreased the levels of LPO and nitrite/nitrate in normotensive and preeclamptic cord blood RBC. M. purpureus was more effective in inhibiting LPO formation compared to S. cerevisiae. In contrast, S. cerevisiae exhibited a signifi cant effect in preventing the formation of nitrite and nitrate levels in cord blood RBC of both subjects. The medicinal value of M. purpureus in various clinical conditions has been well demonstrated, while the medicinal value of S. cerevisiae has seldom been demonstrated. A study by Moyad et al (39) has demonstrated the usage of Epicor, a yeastbased product against common cold and fl u. The latter study is the only report analyzing the medicinal property of S. cerevisiae. The present study is the fi rst of its kind to demonstrate the medicinal value of both M. purpureus and S. cerevisiae under conditions of preeclamptic pregnancy.
Conclusion
This study results conclude that anti-hemolytic and antioxidant properties of S. cerevisiae which is mainly considered as nutritive yeast equal those of M. purpureus. The research work also demonstrates for the fi rst time that diet enriched with yeasts like M. purpureus and S. cerevisiae could serve as a natural antioxidant source and good probiotic supplement for preeclamptic patients. It protects the fetus from ROS-mediated damage by stabilizing the oxidative stress-antioxidant status imbalance as well as by inhibiting ROS-mediated RBC hemolysis under such conditions.
